A detailed history of Boothbay Fund Management, LLC transactions in Cerus Corp stock. As of the latest transaction made, Boothbay Fund Management, LLC holds 40,189 shares of CERS stock, worth $71,938. This represents 0.0% of its overall portfolio holdings.

Number of Shares
40,189
Holding current value
$71,938
% of portfolio
0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$1.7 - $2.39 $68,321 - $96,051
40,189 New
40,189 $69,000
Q1 2024

May 15, 2024

SELL
$1.66 - $2.42 $10,122 - $14,757
-6,098 Reduced 37.18%
10,305 $19,000
Q4 2023

Feb 14, 2024

BUY
$1.25 - $2.35 $20,503 - $38,547
16,403 New
16,403 $35,000
Q2 2022

Aug 15, 2022

SELL
$4.41 - $5.69 $100,852 - $130,124
-22,869 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$4.81 - $6.99 $109,999 - $159,854
22,869 New
22,869 $126,000

Others Institutions Holding CERS

About CERUS CORP


  • Ticker CERS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 177,090,000
  • Market Cap $317M
  • Description
  • Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...
More about CERS
Track This Portfolio

Track Boothbay Fund Management, LLC Portfolio

Follow Boothbay Fund Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boothbay Fund Management, LLC with notifications on news.